Akebia Therapeutics (AKBA) Intangibles (2018 - 2024)
Historic Intangibles for Akebia Therapeutics (AKBA) over the last 7 years, with Q3 2024 value amounting to $9.0 million.
- Akebia Therapeutics' Intangibles fell 7999.91% to $9.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $9.0 million, marking a year-over-year decrease of 7999.91%. This contributed to the annual value of $36.0 million for FY2023, which is 5000.0% down from last year.
- Akebia Therapeutics' Intangibles amounted to $9.0 million in Q3 2024, which was down 7999.91% from $18.0 million recorded in Q2 2024.
- In the past 5 years, Akebia Therapeutics' Intangibles ranged from a high of $282.1 million in Q1 2020 and a low of $9.0 million during Q3 2024
- Moreover, its 5-year median value for Intangibles was $90.1 million (2022), whereas its average is $95.6 million.
- In the last 5 years, Akebia Therapeutics' Intangibles plummeted by 1142.84% in 2020 and then plummeted by 7999.91% in 2024.
- Akebia Therapeutics' Intangibles (Quarter) stood at $144.2 million in 2020, then dropped by 25.0% to $108.1 million in 2021, then crashed by 33.33% to $72.1 million in 2022, then crashed by 50.0% to $36.0 million in 2023, then plummeted by 75.0% to $9.0 million in 2024.
- Its Intangibles was $9.0 million in Q3 2024, compared to $18.0 million in Q2 2024 and $27.0 million in Q1 2024.